3-Azizi F, Etemadi A, Salehi P, ZahediAsl S. Prevalence of metabolic syndrome in an urban population, Tehran Lipid and Glucose Study(TLGS). Tehran Uni Med J 2003; 61(5): 389-99[Persian].
4-Mascarenhas-Melo F, Palavra F, Marado D, Sereno J, Teixeira-Lemos E, Freitas I, "et al". Emergent Biomarkers of Residual Cardiovascular Risk in Patients with Low HDL-c and/or High Triglycerides and Average LDL-c Concentrations: Focus on HDL Subpopulations, Oxidized LDL, Adiponectin, and Uric Acid. Scientific World Journal 2013Nov; (2013): 387849. doi: 10.1155/2013/387849.
5- Miller M, Stone NJ, Ballantyne C, Bittner V, Criqui MH, Ginsberg HN. Triglycerides and Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation 2011May; 123(20): 2292-333.
11-Malek M, Ghorbani R, Rashidi pour A, Eskandarian R. Prevalence of Low HDL-C- High TG syndrome in SemnanProviance(2005). Iranian Diabetes Lipid J 2009; 9(1); 75-80.[In Persian].
18-
Connelly PW,
Petrasovits A,
Stachenko S,
MacLean DR,
Little JA, "et al". Prevalence of highplasmatriglyceridecombined with lowHDL-Clevels and its association with smoking, hypertension, obesity, diabetes, sedentariness and LDL-Clevels in the Canadianpopulation. Canadian Heart Health Surveys Research Group.
Can J Cardiol 1999Apr; 15(4): 428-33.
21-
Sarrafzdegan N ,
Mohammadifard N ,
Rafiy M. A survey of prevalence of hypertriglyceridemia and low HDL in the population of Isfahan with age over 20 years. Tehran Univ Med J1998; 56 (2): 49-56.